Vanessa Almendro

Vanessa Almendro

Company: Eisai Center for Genetics Guided Dementia Discovery (G2D2)

Job title: Head of Strategy & External Innovation

Seminars:

Q&A Panel Discussion 9:15 am

Read more

day: Day One

Market Trends in the Use of Nucleic Acid Technologies to Treat Neurological Disorders 8:35 am

• Focusing on how novel technologies in the nucleic acid space (gene therapies, ASOs, gene editing) will shape the market in neurological indications • Exploring the use of these technologies in large indications (e.g, Alzheimers) compare to rare diseases • How this supposes a paradigm shift at so many levels (for industry, CMOs, practitioners, payers…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.